larixol hamilelikte güvenli mi?

Related ingredients

Frequently asked questions

larixol hamilelikte güvenli mi?

No harmonised CLP classification (no H360/H361), no SCCS or CIR safety assessment located, and no reproductive or developmental toxicity data in PubMed for larixol. Available sources describe pharmacology (TRPC6/fMLP activity) but not teratogenic or reproductive effects; supplier SDSs list no GHS reproductive hazard. (PubMed studies; supplier SDS; ECHA search showing no harmonised classification).

larixol emzirirken güvenli mi?

No data indicating reproductive/developmental or lactation-specific toxicity, no harmonised classification, and no regulatory safety assessment (SCCS/CIR) raising concern. Peer‑reviewed literature describes TRPC6 and immunomodulatory activity but not effects on lactation or milk transfer. (PubMed; supplier SDS; ECHA/C&L checks).

larixol bebek cildi için güvenli mi?

No evidence of a reproductive or developmental hazard specific to infants. Dermal absorption data for larixol were not found; as a moderately lipophilic diterpenoid used at low concentrations in formulations (patent/product listings), systemic exposure from cosmetic topical use appears low for adults (scored e=0). Per instructions, infant skin has higher absorption potential, so exposure score increased by +1 for babies (e=1) in absence of data. No infant-specific toxicity data were found. (Patents/product listings; supplier pages; absence of SCCS/CIR).

VeriMom larixol nasıl puanlıyor?

VeriMom larixol'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.

Hamilelikte larixol yerine neler kullanılabilir?

Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.